Recent

% | $
Quotes you view appear here for quick access.

CC MEDİA HOLDİNG CLA Message Board

wyattkap 217 posts  |  Last Activity: 13 minutes ago Member since: Jun 10, 1998
  • Reply to

    Did or Did Not Sr Mgmt say.....

    by mr_red_rover 22 hours ago
    wyattkap wyattkap 13 minutes ago Flag

    Based on what I see in the time table for data and the need to restock the funds with no less than 2 quarters of cash available. AUGUST should be the sweet spot for a deal. Could go into SEPT, but that is the ballpark I see. This should give us great data on single and maybe two doses at 5mg and 6mg that moves their theories forward as they see it unfolding in all the trials. I was also very excited to see the 521 trial to be just 3 doses at 2,4,6mg levels. Drilling down to the least number of doses with the best dose level is what Monarch and 2001 Extended is all about. Have a great 4th EVERYONE! Summer will be fun and stressful for some as this is the quarter I see it being disclosed and funds invested to set up the next 2-3 years of science leaps forward with diversifications via the DPC. IMO

    Sentiment: Strong Buy

  • Reply to

    Did or Did Not Sr Mgmt say.....

    by mr_red_rover 22 hours ago
    wyattkap wyattkap 15 hours ago Flag

    As I've clearly stated SEVERAL times, when they announced the addition of 5mg & 6mg doses AND it was started in early June, I felt they would hold off till they had solid KD numbers for at least 60 days after the first dose. As I've said before, ENJOY YOUR SUMMER!!!

    Sentiment: Strong Buy

  • Reply to

    Did or Did Not Sr Mgmt say.....

    by mr_red_rover 22 hours ago
    wyattkap wyattkap 19 hours ago Flag

    I don't think for one second they are waiting for such a intersection of depleted funds and known data. I don't think they will go beyond 2 full quarters of cash. IMO that is news in Aug and maybe early Sept.

    I do understand the more we know about our results the more we can expect to receive and this is a MULTI-BILLION dollar market each year and those milestone payments can ramp up big via the data from one month to the next. That is the whole point of my comments that our TeamARWR must be seeing amazing data to push it this far down the road to get to the negotiation level that funds us for a decade without income. All my opinion, but these are smart folks doing our work for us and they have a great track record IMO to get us here were we are in these specific trials going after this large market all others have failed at. Have a great 4th EVERYONE!

    Sentiment: Strong Buy

  • Reply to

    Did or Did Not Sr Mgmt say.....

    by mr_red_rover 22 hours ago
    wyattkap wyattkap 20 hours ago Flag

    Impossible to play Tuesday after quarterback when WE DON'T SEE THE SCIENCE our TeamARWR are seeing. IMO, if the science was just GOOD, we would have had a deal a good while ago to get us another 1 to 2 years down the road, BUT, There is a reason we have no deal YET, as the leverage is still in play and I'll assume the deal gotten 6 months ago is most probably still on the table.

    Look what the design of Monarch and 201-Extended were structured to accomplish? The open label learning goal is to find the best formula to reach our goals. It is fully underway and those daily results are pilling in. WHY BE IN A HURRY when the data is all on your side and each day forward adds to the value of the deal??????? Just sayin!

    Sentiment: Strong Buy

  • Reply to

    Did or Did Not Sr Mgmt say.....

    by mr_red_rover 22 hours ago
    wyattkap wyattkap 21 hours ago Flag

    Depends on your definition of NON Dilutive? The general feeling is that no additional stock will be issued for the capital invested and tied to a clear marketing agreement. BUT-giving up sales % is dilutive via the sales profits that must be given up for another company to market and sell our product. I feel that is why we are not seeing a fast deal, but one that takes us as far down the FC path as possible to greatly enhance our leverage in any dealings.
    TWO key points I see happening or not happening. 1) IF we didn't have great science being seen by TeamARWR this late in the need to comfort stockholders on shoring up the financial strength of the company, We would have seen a deal many months ago IMO. PLUS-2) we would have seen a exit of several key employees by now. Food for thought as I feel we will soon be a member of the Billion Dollar Company Club and please enjoy your Holiday Weekend EVERYONE!

    Sentiment: Strong Buy

  • Reply to

    Short covering going on - look at the volume

    by salivabeast24 Jun 29, 2016 3:54 PM
    wyattkap wyattkap Jun 29, 2016 5:06 PM Flag

    A hefty $280 MILLION dollar Short BBQ and all in ONE DAY! Great way to start out the summer. I'm in another with big shorts playing around ARWR and hope to see a Short BBQ by August!!! Congrats to the longs here!!! You can't argue with the science.

  • Reply to

    Check out TSRO for a nice pop

    by end2war Jun 29, 2016 9:15 AM
    wyattkap wyattkap Jun 29, 2016 10:34 AM Flag

    Well stated and exactly why I'm here, PLUS the broad opportunities the DPC platform opens up towards via getting that one under our belt. Amazing Leverage here. Way to good to ignore and a must play. Have a great week end2war! I now see the TSRO shorts are now down over $300 MILLION (about what the company is reporting in Cash). It can all evaporate FAST.

    Sentiment: Strong Buy

  • Reply to

    Check out TSRO for a nice pop

    by end2war Jun 29, 2016 9:15 AM
    wyattkap wyattkap Jun 29, 2016 10:03 AM Flag

    Ph3 trial that showed extending life about 16 months vs placebo (no cure of any kind) and now showing a $3.4 BILLION Market Cap (about 10 times our numbers). See they had over 7 MILLION short shares that just got whacked over $250 MILLION today. Hmmmm, helping-saving 1,000,000 lives/year via 520/521 looks mighty promising IMO. Just saying??? Love our leverage to upside potential.

    Sentiment: Strong Buy

  • Reply to

    All Around, Serious A.E."s

    by investron Jun 27, 2016 9:13 PM
    wyattkap wyattkap Jun 28, 2016 11:09 AM Flag

    But ONE CURING DEAL has added about $80-90 BILLION to their market cap at todays price over a few short years AND they have over $25 Billion in growing cash for the next big thing to raise it's head for a grab and push opportunity. Clearly down from the entire Biotech market weakness and of course many others trying to nip away at their HepC products MASSIVE PROFITS. New CEO is home grown by GILD and doing just fine IMO. Not ONE other Biotech in the world wouldn't switch their issues with GILD's issues. Have a GREAT WEEK!!

    Sentiment: Strong Buy

  • Reply to

    All Around, Serious A.E."s

    by investron Jun 27, 2016 9:13 PM
    wyattkap wyattkap Jun 28, 2016 10:32 AM Flag

    Gee-didn't ONE CURE via HepC add over $140 BILLION in Market Cap at one point to GILD stock???? I think it did!!! The smart market dumped their stock when they purchased the PH2 Product, and all called their management team stupid for paying so much, but who got the last laugh on that one????? Those darn TeamGILD members. Smartest deal and team of the decade. IMO

    Sentiment: Strong Buy

  • Reply to

    Arrowhead Sub-$5, Sub-$4, Sub-$3

    by ilmplm Jun 27, 2016 10:08 PM
    wyattkap wyattkap Jun 28, 2016 10:08 AM Flag

    Quick glance at your last BIG prediction for ARWR about 10 months ago:

    ilmplm • Aug 14, 2015 7:33 PM

    0 users liked this posts
    users disliked this posts 3 Reply

    Arrowhead will never see $6 again.
    On AD it will be sub $1
    Seeing is believing "You will see it but the longs on this board will still not believe it"
    These long investors are just throughing thier money away by investing in broken Arrowhead.

    Hmmm, not even close and thus you earn no cigar!!! Kind of ugly to read your posts on a half dozen companies as you have 100% bashing and name calling. Also in every post you use the word "THEIR" you misspell it every time. Have a great week!

    Sentiment: Strong Buy

  • Reply to

    All Around, Serious A.E."s

    by investron Jun 27, 2016 9:13 PM
    wyattkap wyattkap Jun 28, 2016 8:16 AM Flag

    Every cure makes money. As we reach ONE very soon, we have 30,000 more to conquer. HepB is just a drop in the bucket of potential. Value of a PLATFORM??? Well over $5 for sure.

    Sentiment: Strong Buy

  • Reply to

    Vanguard ARWR holdings

    by landfall_ahead Jun 18, 2016 9:54 AM
    wyattkap wyattkap Jun 18, 2016 1:34 PM Flag

    Maybe they covered their short position with their own boxed stock????? Thus they have a huge profit, eliminated ALL RISK, AND own a very promising FREE 1 million share position??????? Have a great summer everyone!!! Going to be great fun watching the trial progress roll out over the next few months. Well, Cleveland did what I expected them to do and now we have a GREAT SUNDAY game to see who wants it most!!

    Sentiment: Strong Buy

  • KEYTRUDA® (pembrolizumab) is a medicine that may treat your melanoma or lung cancer by working with your immune system. KEYTRUDA can cause your immune system to attack normal organs and tissues in many areas of your body and can affect the way they work.

    Sentiment: Strong Buy

  • wyattkap wyattkap Jun 16, 2016 1:04 PM Flag

    Well stated Bourbonisbest: further, about 8 years ago my dad had severe heart issues and he went through a 48 IV dose of chelation (sp?) every week. I dropped him off at a clinic setup just for this special IV treatment. The room had 30 Lazy-boy chairs in a big circle and each IV treatment took about 90 minutes.

    My dad like it because he could talk to others during the IV treatments that were far more ahead in their treatments and that motivated him & others to keep coming in due to their success reported by the other patients. I'm sure that was part of the clinics model to help folks through a long process like this. They also had headphones and you could bring in your music or listen to a clinic recording that talked about what they were doing and why. They tried to educate their patients, but the most effective results were from meeting others with your similar issues and that even generated REFERRALS to the Clinic!

    I see a model like this taking off that becomes a profit center for many doctors. I understood that doctors that referred a patient to the special clinic got a kickback of some kind.

    It appears to me that ARWR is trying to get this down to 1-3 IV (30 min or less) doses, so a model like this could be very successful in areas of the world with high infection numbers and families. Patients telling other patients of their positive progress in a round circle environment increases participants AND can increase prices for higher profits. Mini-clinics that only deal with HepB and or other IV injected products could pop up where feasible. Could continue even if we reach SubQ applications. Doctors could just refer to the special clinics in their area, get compensated and move to their next dozen patients. Also provides a great blood testing site for added profits to the clinics and convenience to the patients for easy monitoring of the progress. Any challenge requires a smarter model to meet the needs.

    Sentiment: Strong Buy

  • Reply to

    ARWR - what calls to get?

    by marioseamus715 Jun 16, 2016 10:05 AM
    wyattkap wyattkap Jun 16, 2016 11:43 AM Flag

    I had a conversation about this very subject two days ago with a good friend I met here on this YB and we got together a few weekends ago. Our deduction told us that our GREED told us to buy the Jan 2017 Calls, Our Investor hunch told us to spend more and buy the Jan 2018 $10 Calls to greatly reduce risk. I have BOTH Jan 2017 & 2018 in a balance strategy as I believe in the science, but the time table with new science is always a big unknown. $5 & $10 at 2017-Jan, and $10 at 2018-Jan. BEST is to always own the stock, but the options market is fun to dabble in when you see great values in very ugly moments in stock trading.. Good Luck to All! AND go Cleveland, I'd love to see a GAME 7.

    Sentiment: Strong Buy

  • wyattkap wyattkap Jun 15, 2016 3:46 PM Flag

    The SIMPLE thread of reasoning is that the current platform of IV use in both 520 & 521 (with success) will get us into the Billion Dollar Club. That will lead us with the resources towards expanding our markets, create a SQ option that also would further extend the marketability & patent protection, plus drive more value to the many other drug candidates under study and trials using the same DPC platform.

    My simple opinion is, Wasting time to worry about IV having difficulties getting patients in a massive 400 Million Patent Pool is RIDICULOUS and very FUNNY by all you bashers to keep regurgitating. But name calling is your priority-you all are good at that.

    PLEASE put me back on Ignore, the likes of Holden and others can contact you directly at any time. OH-Wait, I see no one finds you worthy for such limited efforts to take any subject further in private. I'd say that just might be a MUCH better example of being a 'LOW VALUE" pumper.

    Its June and grade schools are closed for the summer. I'm Done posting back to you. Have a great summer!!!

    Sentiment: Strong Buy

  • wyattkap wyattkap Jun 15, 2016 1:05 PM Flag

    Why is it stupid???? Try 400 million sick people to answer your question and how many need to come in for IV treatments to make this a massive block buster??? We are talking about one of the largest markets in the ENTIRE WORLD are we not???

    JUST 1% would mean 4 MILLION FOLKS and what could that market size be??? $5,000 per patient and we see $20 BILLION in potential over several years???? Put any number you want on it, the KEY is whose shoes are you standing in and we are looking at the LARGEST DRUG MARKET IN THE WORLD.

    Recall that 700K to 1 MILLION souls/year are at stake and you worry about marketability at this early stage??? Many drugs start out as an IV and then move towards shots and then pills, I would expect the same advancements here, but it starts somewhere and SAVING LIVES HAS MARKETABILITY WRITTEN ALL OVER IT???

    Holden is picking up his refurbished One-half#$%$-shot-will-do-the-job-bat as we speak and it ain't for me!!!! As you said-try reasoning and evidence with a little commons sense before your love to name call is irresistible to yourself. We talking about a solution to one of the largest markets in the world.

    Sentiment: Strong Buy

  • wyattkap wyattkap Jun 15, 2016 12:06 PM Flag

    Lengthy IVs and many no shows??? Are we back to that STUPIDITY & Re-Hashing?? Why not ask the 3 to 10 MILLION folks that will die over the next 3 to 10 years from HepB complications how they would feel about coming in 1,2,3,4 or even 5 times for a 20-30 minute IV once a month to reduce or eliminate their fear of getting HepB caused cancer, getting very sick so they can't work, staying in a hospital that last few months of their lives as their family sits and watches them die, experiencing massive pain from the illness complications---- this sickness could be prevented, but you must take a total of 5-10 hours out of your life to get those few needed IV treatments to eliminate your HepB issues. GEE-I think it depends on whose shoes you are standing in to make that call????? Here is a great example of a posting thread as to why the likes of Holden is off doing more productive things with his time and investing life. Constant Re-Hashing STUPIDITY!!!! Enjoy your week everyone and good luck to those Cleveland Fans to even up the score to maybe reach a great game 7 experience. No NBA team has ever come from a 3-1 deficit (30-0) but this appears to be the year to break records???? I'm a fan of both teams, so I win either way!!! SUPER Strong BUY HERE!

    Sentiment: Strong Buy

  • Reply to

    VERY POSITIVE POINT seen in the 521 Trial Design

    by wyattkap Jun 14, 2016 10:47 AM
    wyattkap wyattkap Jun 15, 2016 9:30 AM Flag

    I feel the insiders that are seeing the data are potential marketing partners ONLY, NO INVESTORS ALLOWED. Strict Control of the information is essential. Thus the low to normal volume.

    Sentiment: Strong Buy